What’s New


Jan 8, 2024

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. Th…


Nov 8, 2023

Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial in…


Aug 2, 2023

Samples, Assays, and Analyses: Building a Biomarker Plan for Precision Medicine in Clinical Trials

Designing a biomarker plan for a clinical trial can be challenging due to the plethora of assays and advancing technologies that are now readily available. A well-defined biomarker plan sets the stage…